Skip to main content
Fig. 5 | BMC Endocrine Disorders

Fig. 5

From: A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis

Fig. 5

a miR-145 expression levels in 24 SI-NETs, and in CNDT2.5. A significant (p < 0.01) difference between primary tumors and liver metastases, and also between lymph node and liver metastasis (p < 0.001) was observed. A tendency towards decreased expression in lymph node metastases compared to primary tumors was detected (p = 0.09). b ACTG2 mRNA expression levels in 18 PT and 16 LNM. A significant (p < 0.01) difference between primary tumors and lymph node metastases was observed. PT, primary tumor. LNM, lymph node metastasis. LM, liver metastasis

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us